ISMJ

Ethical considerations

Ethical considerations must be addressed in the Materials and Methods section.
1) Please state that informed consent was obtained from all  human adult participants and from the parents or legal guardians of minors. Include the name of the appropriate institutional review board that approved the project.
2) Indicate in the text that the maintenance and care of experimental animals complies with National Institutes of Health guidelines for the humane use of laboratory animals, or those of your Institute or agency.

 Plagiarism Policy:

(a) Suspected plagiarism in a submitted manuscript 

(b) Suspected plagiarism in a published manuscript 

Authorship Criteria

Iranian South Medical Journal is committed to follow and apply “International Standards for Authors” of Committee on Publication Ethics (COPE) in designing and leading the Journal’s reviewing and publishing process and dealing with their issues. 

Current definitions of authorship Editorial or academic organisations within different specialties have set out criteria and guidelines that members could adopt in their consideration of authorship. A selection of them is presented below.

The International Committee of Medical Journal Editors (ICMJE) recommends that authorship be based on the following 4 criteria:

1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Conflict of Interest Declaration

A conflict of interest statement for categoried all article and research study is necessary. Because of the interests of transparency and assisting reviewers to evaluate any potential bias in a investigation’s design, interpretation of it findings or demonstration of its scientific/medical content, Iran South Med J necessitates all authors of each article to state any conflicting interests (including but not restricted to commercial, individual, political, intellectual, or religious interests) in the title page that are associated to the project submitted for contemplation of publication. Furthermore, reviewers are necessitated to point out any potential conflicting interests they might have associated to any specific article they are requested to review, and a copy of signed declaration should be made available to the Iran South Med J.

Articles should be published with statements or supporting documents, such as the ICMJE conflict of interest form, declaring:

• Authors’ conflicts of interest; and
• Sources of support for the work, including sponsor names along with explanations of the role of those sources if any in study design; collection, analysis, and interpretation of data; writing of the report; the decision to submit the report for publication; or a statement declaring that the supporting source had no such involvement; and
• Whether the authors had access to the study data, with an explanation of the nature and extent of access, including whether access is on-going.

Example wording: [Name of person] has received fees for working as a researcher /speaker, a [position; such as mentor and/or an advisory board member] for [name(s) of organization(s)]. [Name of person] has granted funding from [name(s) of organization(s)]. [Name of person] is a member of staff of [name(s) of organization(s)]. [Name of person] possess stocks and/or shares in [name(s) of organization(s)]. [Name of person] possess patent [patent identifier information (including patent number, two-letter country code, and kind code) and a short explanation].

Somethings that Authors should Know befor submitting a Manuscript:

 Redundant or Duplicate Publication

Redundant or duplicate publication is publication of a paper that overlaps substantially with one al­ready published.

Readers of primary source periodicals deserve to be able to trust that what they are reading is original unless there is a clear statement that the article is being republished by the choice of the author and editor. The bases of this position are international copyright laws, ethical conduct, and cost-effective use of re­sources.

This policy does not preclude the journal considering a paper that has been rejected by another journal, or a complete report that follows publication of a preliminary report, such as an abstract or poster dis­played for colleagues at a professional meeting. Nor does it prevent journals considering a paper that has been presented at a scientific meeting but not published in full or that is being considered for publication in a proceedings or similar format. Press reports of scheduled meetings will not usually be regarded as breaches of this rule, but such reports should not be amplified by additional data or copies of tables and il­lustrations.

When submitting a paper, the author should always make a full statement to the editor about all sub­missions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work. The author should alert the editor if the work includes subjects about which a previous report has been published. Any such work should be referred to and referenced in the new paper. Copies of such material should be included with the submitted paper to help the editor decide how to handle the matter.

 If redundant or duplicate publication is attempted or occurs without such notification, authors should expect editorial action to be taken. At the least, prompt rejection of the submitted manuscript should be expected.

 Preliminary release, usually to public media, of scientific information described in a paper that has been accepted but not yet published violates the policies of many journals. In a few cases, and only by arrangement with the editor, preliminary release of data may be acceptable-for example, if there is a pub­lic health emergency.

Acceptable Secondary Publication

Secondary publication in the same or another language, especially in other countries, is justifiable, and can be benefi­cial, provided all of the following conditions are met.

  1. The authors have received approval from the editors of both journals; the editor concerned with secondary publica­tion must have a photocopy, reprint, or manuscript of the pri­mary version.

  2. The priority of the primary publication is respected by a publication interval of at least one week (unless specifically negotiated otherwise by both editors).

  3. The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.

  4. The secondary version faithfully reflects the data and in­terpretations of the primary version.

  5. The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the pa­per has been published in whole or in part and states the pri­mary reference. A suitable footnote might read: “This article is based on a study first reported in the [title of journal, with full reference].”

  Permission for such secondary publication should be free of charge.

Protection of Patients’ Rights to Privacy

Patients have a right to privacy that should not be infringed without in­formed consent. Identifying informa­tion should not be published in written descriptions, photographs, and pedi­grees unless the information is essen­tial for scientific purposes and the pa­tient (or parent or guardian) gives written informed consent for publica­tion. Informed consent for this pur­pose requires that the patient be shown the manuscript to be published.

Identifying details should be omit­ted if they are not essential, but patient data should never be altered or falsi­fied in an attempt to attain anonymity. Complete anonymity is difficult to achieve, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

Submission Process

Manuscript must be sent in MS-WORD file format through the on-line submission system: (www.manuscriptonline.com).

The manuscript should include Title page, the Abstract, Introduction, Methods, Results, Discussion and Conclusion, Acknowledgement, attachments (tables, figures, graphs), All in Farsi, References, and anAbstract in English.

  Cover Letter

 Please define that you will not resubmit your article to another journal until the reviewing process will be completed. Get the Covering Letter Form (Available form http://ismj.bpums.ac.ir/page/79/%D8%B1%D8%A7%D9%87%D9%86%D9%85%D8%A7%DB%8C-%D9%82%D8%A8%D9%84-%D8%A7%D8%B2-%D8%A7%D8%B1%D8%B3%D8%A7%D9%84-%D9%85%D9%82%D8%A7%D9%84%D9%87),fill it up, and send it back by article through the on-line submission system.

 Assignment of Copyright and Authorship Responsibilities

 Your article will not be published unless a Copyright Assignment Form has been signed and received Iran South Med J (Available form http://ismj.bpums.ac.ir). You hereby warrant that “This article is an original work, has been published before and is not being considered for publication elsewhere in its final form either in printed or electronic form”.

The Editor-in-Chief, Majid Assadi, MD

Iranian South Medical Journal

P.O.Box: 7514763448, Iran

Tel: +98 77 33331827

Fax: +98 77 33331828

Email: ismjbpums.ac.ir

URL: ismj.bpums.ac.ir

URL page: http://ismj.bpums.ac.ir/find.php?item=1.70.25.en